AzTrials
AzTrials

PretermCORINCT06753435

Co-regulation and Interaction in the NICU

An observational study of Preterm, run by Linkoeping University at 1 site in Sweden.

Recruiting

Looking for participants now. Contact the study team or a site below to ask about taking part.

Sites and contacts
Official record
Search all trials

Trial summary

Preterm infants are exposed to multiple stressors each day, posing a risk of toxic stress that can impact their developing brains during a critical period of sensitivity. Elevated levels of the stress hormone cortisol can impede neuronal connectivity and communication, thereby increasing the likelihood of cognitive… Read more about this study

Who is it for?
Ages 2 days and olderHealthy volunteers can take part
Conditions the study is for
Preterm
How many people
105 participants
Where
1 siteSweden
Study dates
7 Jan 2025to Dec 2031
Phase
Observational
Are there results?
Not yet: the study is under way

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 2 days and older
  • All sexes
  • Healthy volunteers accepted
  • Child, Adult, Older adult

Study population: Infants born preterm between 30+0 and 34+6 weeks gestational age and their parents > 18 years old

Who may be able to join

  • Swedish- or English-speaking parents aged over 18, born in Europe, and their infants born between gestational weeks 30+0 and 34+6.

Who cannot join

  • Parents with conditions or taking medications affecting the hormone system. Additionally, infants with major malformations or complex care needs that impede interaction possibilities are excluded.

Trial locations and contacts

1 site in 1 country. Contact the study team or a site near you to ask about taking part.

Evalotte Mörelius, PhD, Professor contact

+46 (0) 793008207

evalotte.morelius@liu.se

Sweden1 site, 1 recruiting
  • H.R.H Crown Princess Victoria's Children's and Youth Hospital

    Linköping, 58185

    Neonatal Intensive Care Unit, +46 (0)10 103 00 00, BarnUsBkc@regionostergotland.se

    Evalotte Mörelius, RN, PhD, Professor

    Recruiting

Other trials in Sweden

About this study

Official title: Development of the Premature Infant's Stress System. Focus on Parent-infant Co-regulation and Interaction

Preterm infants are exposed to multiple stressors each day, posing a risk of toxic stress that can impact their developing brains during a critical period of sensitivity. Elevated levels of the stress hormone cortisol can impede neuronal connectivity and communication, thereby increasing the likelihood of cognitive impairment and behavioural problems. Synchronized social-emotional mother-infant interaction holds promise in buffering stress reactivity and mitigating long-term stress effects.

Our previous research has shown that preterm infants exhibit higher baseline saliva cortisol levels than full-term infants, along with blunted cortisol reactivity to stressors, irregular cortisol circadian rhythms, and delayed cortisol co-regulation between mother and infant. Another potential stress marker is saliva alpha-amylase (α-amylase), which has garnered increasing interest in adult research. However, there remains a significant gap in the literature concerning saliva α-amylase as a stress marker in preterm infants, warranting further investigation. The overall aim is to study development and relationships between three systems of parent-infant synchrony in preterm infants and their parents and elucidate potential confounding factors for a synchronous correlation. This will be done in relation to standardised care procedures commonly performed in the neonatal intensive care unit.

Read more

This observational study will involve 35 families undergoing three video-recorded procedures in the NICU. Saliva will be collected from infants and both parents before and after each procedure so we can analyse co-regulation of cortisol and alpha-amylase. Parent-infant interaction will be analysed from the videos using validated scales.

This study will be the first to document biological co-regulation and social-emotional parent-infant interaction simultaneously involving preterm infants and both parents in the NICU setting. Such insights are pivotal for the future design and implementation of tailored nursing interventions aimed at early stress mitigation, thereby reducing the risk of stress-related consequences.

Read the detailed description

This observational study adopts a correlational approach to investigate biological co-regulation and parent-infant interaction within families of preterm infants, utilizing a within-family design. Data collection occurs at multiple time points in the NICU, and at 6 and 12 months corrected age. To study parent-infant synchrony and co-regulation with both parents, both should be present and perform three diaper changes in three days. Two will be perforemd by the mother and one by the father. All occassions will be video recorded to study interaction and saliva will be collected before and after the procedure to study co-regulation in cortisol and alpha-amylase during baseline, reactivity and recocvery. At 6 and 12 months parents will respond to questionnaires regarding the child's behavior and development.

Sample size: A power calculation shows sample size of n=28 is sufficient, considering α (two-tailed) = 0.05, β = 0.20, and ICC = 0.5.To consider attrition, we paln to include 35 families.

Conditions
Preterm
Keywords
Preterm infant, Stress system, Family
Medical subject headings
Premature Birth

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

Study groups in NCT06753435
Study groupRoleWhat they receive
Families of preterm babies born at GA 30+0-34+6 enrolled in NICUNot described

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Saliva cortisol correlation (co-regulation) within the triad (mother, father, infant)

    Saliva will be collected from the infant and both parents before (baseline) and at 20 minutes (reactivity), and 40 minutes (recovery) after a diaper change performed three times in three days. Samples will be collected using swabs and stored frozen (-80C) until analysis. Cortisol will be analysed at Linköping University (LiU).

    Measured: GW 32 +/- 2 weeks

  2. Saliva Alpha-amylase correlation (co-regulation) within the triad (mother, father, infant)

    Saliva α-amylase will be collected from the infant and both parents before (baseline) and at 5 minutes (reactivity), 20 minutes (recovery) after a diaper change performed three times in three days. Samples will be collected using swabs and stored frozen (-80C) until analysis. α-amylase levels will be analysed at Linköping University (LiU).

    Measured: GW 32 +/- 2 weeks

  3. Parent-infant emotional availability

    All three diaper changes will be video recorded with both parents present and instructed to act as they normally would. Emotional availability will be evaluated from videos using the Emotional Availability Scales (EAS) by certified coders. EAS assesses dyadic and emotional qualities of parent-infant relationships across six sub-scales, with dimensions measured using a Likert-scale ranging from 1 to 7, higher scores indicate better emotional availability.

    Measured: GW 32 +/- 2 weeks

  4. Parent-infant synchrony

    All three diaper changes will be video recorded with both parents present and instructed to act as they normally would. Parent-infant synchrony will be assessed from the videos using the Dyadic Mini Code, which includes six categories: mutual attention, positive affect, turn-taking, parental pauses, infant cues, and parental sensitive responsiveness. Scores range from 6 to 12, with ≥10 indicating synchronous interaction.

    Measured: GW 32 +/- 2 weeks

  5. Parent-infant interaction

    All three diaper changes will be video recorded with both parents present and instructed to act as they normally would. Parent sensitivity towards the infant will be assessed from the videos using Ainsworth's Sensitivity Scales. This instrument constitutes of four sub-scales measuring sensitivity, cooperation, availability and acceptance. Each scale range 1-9, where higher scores indicate better interactive behaviour.

    Measured: GW 32 +/- 2 weeks

Secondary outcomes (4)
  1. Skin temperature in mother, father and infant

    Correlation of skin temperature in the triad will be measured at the forehead on infants and both parents before and after each diaper change with an infrared thermometer. This method is painless as the temperature can be assessed without touching the infant.

    Measured: GW 32 +/- 2 weeks

  2. Infant development

    The Swedish Ages and Stages Questionnaire: Social Emotional (ASQSE2) is a 25-item tool assessing children's social-emotional development.

    Measured: 6 and 12 months corrected age, +/-2 months

  3. Infant temperament

    Infant Behaviour Questionnaire-Revised short form, which assesses infants' temperament across three main components (negative emotionality, positive affectivity/surgency, and orienting/regulatory capacity), will be administered when infants are 6 and 12 months corrected age. This questionnaire includes 14 scales measured on 7-point-scales. A min-max score for each scale is 1-7 where 7 indicates a higher frequency of the specific behaviours being measured.

    Measured: 6 and 12 months corrected age, +/-2 months

  4. Communicative Skills and Language Abilities

    The Early Communicative Development Inventories (words \& gestures), assess communicative skills and language abilities of infants aged 8-16 months. The Swedish version will be used to evaluate the child's understanding of words, vocabulary, and communicative gestures. Confirmative answers are given in a form of examples.

    Measured: 12 months corrected age, +/-2 months

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted31 Dec 2024
  2. Study start7 Jan 2025
  3. Primary completion31 Dec 2027 (estimated)
  4. Study completionDec 2031 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Observational
Observational model
Family based
Time perspective
Cross-sectional
Enrolment
105 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT06753435
Sponsor's protocol ID
Dnr 2024-02916-01 CORI
Acronym
CORI
Status last verified
Mar 2025
First submitted
12 Dec 2024
Last updated
7 Mar 2025
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
Undecided

Questions about this trial

What is this clinical trial studying?

An observational study of Preterm, run by Linkoeping University at 1 site in Sweden.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 1 inclusion and 1 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: looking for participants now, as of the sponsor's last update on 7 Mar 2025. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Sweden. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

This study is still under way. Results are not available in the source record yet.

How can a doctor refer a patient or contact the research team?

Contact Evalotte Mörelius, PhD, Professor (+46 (0) 793008207, evalotte.morelius@liu.se), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Saliva cortisol correlation (co-regulation) within the triad (mother, father, infant) (time frame: GW 32 +/- 2 weeks). The study lists 5 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 7 Mar 2025.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in